COMMUNIQUÉS West-GlobeNewswire

VALNEVA annonce la mise à disposition des documents préparatoires à l'Assemblée d'actionnaires
07/06/2018
Valneva annonce la mise à disposition des documents préparatoires à l'Assemblée d'actionnaires Lyon (France), 7 juin 2018 - Les actionnaires de la société Valneva SE (ci-après "Valneva" ou "la Société") sont invités à [...]
Shire plc : Rule 2.9 Announcement
07/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 June 2018 Shire [...]
B-Temia and Wistron Join Forces to Launch Keeogo™ in Asia
07/06/2018
B-Temia and Wistron form B-Temia Asia to bring Keeogo™ to the Asian Market QUEBEC CITY, June 07, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotics technology company and market leader in human mobility, [...]
Athersys Announces Expansion of Collaboration With Healios
07/06/2018
Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million in license fees, plus potential milestones payments and royalties Discussions extended for China and other [...]
General Meeting to be held on June 28, 2018 and Availability of Related Materials
07/06/2018
LYON, France, June 07, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP) , a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan [...]
Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.
07/06/2018
Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S. Multiple scientific conference contributions at ASM Microbe highlight benefits of Unyvero LRT First commercial [...]
Madrigal Pharmaceuticals Prices Public Offering of Common Stock
07/06/2018
CONSHOHOCKEN, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic [...]
Optinose Announces Pricing of Public Offering of Common Stock
07/06/2018
YARDLEY, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $22.25 [...]
MPX Appoints Robert Petch to the Board of Directors
07/06/2018
TORONTO, June 06, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that Robert Petch has joined the board of directors of MPX. Mr. Petch has [...]
Arog Pharmaceuticals Announces Clinical Presentations on Crenolanib at the 23rd Congress of the European Hematology Association
07/06/2018
DALLAS, June 06, 2018 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet [...]
XORTX to Commence Trading on the OTCQB Venture Market
06/06/2018
CALGARY, Alberta, June 06, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism
06/06/2018
COPENHAGEN, Denmark, June 06, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director
06/06/2018
VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointment of Mr. Bill Dickie as Chief [...]
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
06/06/2018
TUSTIN, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Align Technology to Speak at Upcoming Financial Conferences
06/06/2018
SAN JOSE, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced that the company is scheduled to speak at upcoming financial conferences. The presentation, as noted below, will [...]
Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 39th Annual Global Healthcare Conference
06/06/2018
CAMBRIDGE, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), today announced that it will present at the Goldman Sachs 39th Annual Global Healthcare Conference. The presentation is [...]
Lundbeck reaches voluntary agreement in principle with U.S. Department of Justice
06/06/2018
Valby, Denmark, 6 June 2018 - H. Lundbeck A/S (Lundbeck) today announced that its U.S. subsidiary Lundbeck LLC has reached an agreement in principle to resolve the U.S. Department of Justice (DOJ) investigation related [...]
National Brain Tumor Society-Championed Childhood Cancer STAR Act Signed Into Law
06/06/2018
Boston, MA, June 06, 2018 (GLOBE NEWSWIRE) -- Today, the Childhood Cancer STAR (Survivorship, Treatment, Access and Research) Act was signed into law. This pivotal moment marks a major victory for brain tumor and [...]
GW Pharmaceuticals to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
06/06/2018
LONDON and CARLSBAD, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]

Pages